Knockout of Purinergic P2Y


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
14 Feb 2023
Historique:
received: 27 12 2022
revised: 10 02 2023
accepted: 13 02 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 3 3 2023
Statut: epublish

Résumé

Nonalcoholic steatohepatitis (NASH) is a disease that progresses from nonalcoholic fatty liver (NAFL) and which is characterized by inflammation and fibrosis. The purinergic P2Y

Identifiants

pubmed: 36835211
pii: ijms24043800
doi: 10.3390/ijms24043800
pmc: PMC9963899
pii:
doi:

Substances chimiques

purinoceptor P2Y6 0
RNA, Messenger 0
Receptors, Purinergic P2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Science and Technology Agency
ID : JPMJCR2024
Organisme : Japan Science and Technology Agency
ID : 22K06630
Organisme : Japan Science and Technology Agency
ID : 22H04814
Organisme : Japan Science and Technology Agency
ID : 21H05269
Organisme : Japan Science and Technology Agency
ID : 22H02772
Organisme : National Research Foundation of Korea
ID : 2017K1A1A2004511

Références

Cancer Cell. 2022 Sep 12;40(9):986-998.e5
pubmed: 36055226
Sci Rep. 2021 Jun 11;11(1):12389
pubmed: 34117330
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30763-30774
pubmed: 33199639
Diabetes. 2011 Feb;60(2):669-79
pubmed: 21270276
J Hepatol. 2018 Mar;68(3):493-504
pubmed: 29080810
J Clin Invest. 2018 Dec 3;128(12):5587-5602
pubmed: 30300140
Mol Pharmacol. 2008 Sep;74(3):777-84
pubmed: 18523137
J Endocrinol. 2019 Sep 1;:
pubmed: 31505462
Sci Signal. 2016 Jan 19;9(411):ra7
pubmed: 26787451
Transl Res. 2017 Apr;182:75-87
pubmed: 28011152
Int J Exp Pathol. 2013 Apr;94(2):93-103
pubmed: 23305254
Int J Mol Sci. 2021 May 24;22(11):
pubmed: 34073834
Hepatology. 2018 Jul;68(1):48-61
pubmed: 29315766
Cells. 2021 Dec 13;10(12):
pubmed: 34944021
Free Radic Biol Med. 2012 May 1;52(9):1666-79
pubmed: 22343416
J Hepatol. 2006 Jun;44(6):1167-74
pubmed: 16618517
Exp Mol Pathol. 2007 Dec;83(3):392-8
pubmed: 17490639
Am J Physiol Gastrointest Liver Physiol. 2013 Dec;305(12):G950-63
pubmed: 24157968
JCI Insight. 2021 May 24;6(10):
pubmed: 34027896
EMBO J. 2008 Dec 3;27(23):3104-15
pubmed: 19008857
J Invest Dermatol. 2022 Sep;142(9):2334-2342.e8
pubmed: 35304248
Br J Pharmacol. 2020 Jun;177(11):2413-2433
pubmed: 32037507
Mayo Clin Proc. 2006 Nov;81(11):1462-71
pubmed: 17120402
J Immunol. 2011 May 1;186(9):5376-87
pubmed: 21444765
Int J Mol Med. 2019 Dec;44(6):2256-2264
pubmed: 31638172
Int J Mol Sci. 2016 Sep 20;17(9):
pubmed: 27657051
J Biol Chem. 2010 Jun 11;285(24):18528-36
pubmed: 20395294
PLoS One. 2012;7(7):e40584
pubmed: 22848385
Atherosclerosis. 2022 Sep;357:51-59
pubmed: 36058083
Hepatology. 2021 Nov;74(5):2452-2466
pubmed: 34105780
Sci Rep. 2017 Apr 10;7(1):771
pubmed: 28396595
Sci Signal. 2022 Jan 11;15(716):eabj0644
pubmed: 35015570
Am J Physiol Gastrointest Liver Physiol. 2004 Aug;287(2):G417-24
pubmed: 14764443
Diabetes. 2014 Mar;63(3):850-66
pubmed: 24194503
Int J Mol Sci. 2021 Feb 21;22(4):
pubmed: 33670021
Int J Mol Sci. 2013 Oct 15;14(10):20704-28
pubmed: 24132155
Br J Pharmacol. 2019 Sep;176(18):3723-3738
pubmed: 31241172
J Lipid Res. 2006 Oct;47(10):2280-90
pubmed: 16829692
Hepatol Res. 2004 Oct;30(2):104-110
pubmed: 15519275
J Hepatol. 2019 Oct;71(4):793-801
pubmed: 31279902
ACS Omega. 2017 Mar 31;2(3):1207-1214
pubmed: 28393137
Diabetes Metab Res Rev. 2003 May-Jun;19(3):209-15
pubmed: 12789654
Sci Rep. 2019 May 20;9(1):7580
pubmed: 31110304
Pharmacol Ther. 2017 Dec;180:113-128
pubmed: 28648830
J Neuroinflammation. 2017 Feb 20;14(1):38
pubmed: 28219441
Nature. 2022 Oct;610(7932):562-568
pubmed: 36261549
Cell Rep. 2021 Dec 28;37(13):110148
pubmed: 34965424
Nature. 2007 Apr 26;446(7139):1091-5
pubmed: 17410128
Neuropharmacology. 2016 May;104:50-61
pubmed: 26519900
Front Endocrinol (Lausanne). 2021 Aug 11;12:718429
pubmed: 34456873
Toxicology. 2008 Mar 20;245(3):194-205
pubmed: 18291570
Am J Physiol Renal Physiol. 2006 Apr;290(4):F828-37
pubmed: 16332931
Sci Adv. 2021 Jul 28;7(31):
pubmed: 34321199
Biol Pharm Bull. 2021;44(3):431-436
pubmed: 33642551
Circulation. 2012 Jan 17;125(2):354-63
pubmed: 22144568
Biochim Biophys Acta Mol Basis Dis. 2019 Oct 1;1865(10):2595-2605
pubmed: 31271845
J Cell Physiol. 2019 May;234(5):6667-6678
pubmed: 30317589
Purinergic Signal. 2020 Sep;16(3):367-377
pubmed: 32720036
J Immunol. 2004 Jul 1;173(1):21-4
pubmed: 15210754
Sci Rep. 2020 Aug 18;10(1):13926
pubmed: 32811872
Cancers (Basel). 2022 Feb 22;14(5):
pubmed: 35267424
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2237-45
pubmed: 25104800
PeerJ. 2019 Dec 20;7:e8115
pubmed: 31879571
Int Immunopharmacol. 2022 Aug;109:108909
pubmed: 35700583
Clin Sci (Lond). 2012 Sep;123(5):323-32
pubmed: 22439844
Gastroenterology. 2005 Jul;129(1):26-33
pubmed: 16012931
J Clin Invest. 2009 Mar;119(3):582-94
pubmed: 19221436

Auteurs

Kazuhiro Nishiyama (K)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Kohei Ariyoshi (K)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Akiyuki Nishimura (A)

National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences, Okazaki 444-8787, Japan.
Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Okazaki 444-8787, Japan.

Yuri Kato (Y)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Xinya Mi (X)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Hitoshi Kurose (H)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Sang Geon Kim (SG)

College of Pharmacy, Dongguk University-Seoul, Goyang-si 10326, Gyeonggi-Do, Republic of Korea.

Motohiro Nishida (M)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences, Okazaki 444-8787, Japan.
Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Okazaki 444-8787, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH